Catalog No. | HT343066 |
---|---|
Species reactivity | Human |
Applications | ELISA, Functional assay, Research in vivo |
Isotype | Fusion - [ACVR2B (activin A receptor type 2B, ActR-IIB, ActRIIB)]2 - IGHG1 Fc (Fragment constant) |
Expression system | Mammalian Cells |
Target | GDF-8, GDF8, MSTN, Myostatin, Growth/differentiation factor 8 |
Endotoxin level | Please contact the lab for this information. |
Purity | >95% purity as determined by SDS-PAGE. |
Purification | Protein A/G purified from cell culture supernatant. |
Accession | O14793 |
Form | Liquid |
Storage buffer | 0.01M PBS, pH 7.4. |
Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
Alternate Names | ACE-031, ActRIIB-IgG1, ActRIIb:FcFusionProtein, HGT-4510, RAP-031, 1169766-01-1 |
Background | Ramatercept (ACE-031) is a soluble ActRIIB receptor and can be used as a soluble activin receptor 2 (ACVR2) antagonist. Ramatercept inhibits the signal pathway of muscle growth inhibition and has potential application in muscle atrophy. • Targeting the myostatin signaling pathway to treat muscle loss and metabolic dysfunction., PMID:33938454 • Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member., PMID:9139826 • GDF8 inhibition enhances musculoskeletal recovery and mitigates posttraumatic osteoarthritis following joint injury., PMID:38019905 • Growth differentiation factor 8 down-regulates pentraxin 3 in human granulosa cells., PMID:25641196 • Growth differentiation factor myostatin regulates epithelial-mesenchymal transition genes and enhances invasion by increasing serine protease inhibitors E1 and E2 in human trophoblast cells., PMID:37738042 • Growth differentiation factor 8 induces SKOV3 ovarian cancer cell migration and E-cadherin down-regulation., PMID:27481097 • Circulating Growth Differentiation Factor 11/8 Levels Decline With Age., PMID:26489925 • Crystal structure of the WFIKKN2 follistatin domain reveals insight into how it inhibits growth differentiation factor 8 (GDF8) and GDF11., PMID:30814254 • Effects of growth differentiation factor 8 on steroidogenesis in human granulosa-lutein cells., PMID:26607022 • Molecular characterization of latent GDF8 reveals mechanisms of activation., PMID:29348202 |
Note | For research use only. Not suitable for clinical or therapeutic use. |
SDS-PAGE for Research Grade Ramatercept.
+86-027-65523339
Building C, No. 666, Shen Dun Si Lu, Wuhan, 430206, China